✦ LIBER ✦

Managing the Risks of Cardiac Therapy in Cancer Patients

✍ Scribed by Chen, Carol L.; Parameswaran, Rekha

Book ID: 121226345
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 230 KB
Volume: 40
Category: Article
ISSN: 0093-7754
DOI: 10.1053/j.seminoncol.2013.01.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiac Testing to Manage Cardiovascular

Cardiac Testing to Manage Cardiovascular Risk in Cancer Patients

✍ Davis, Margot; Witteles, Ronald M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 651 KB

Managing the risks of IBD therapy

✍ Cynthia H. Seow; Shanika de Silva; Gilaad G. Kaplan; Shane M. Devlin; Subrata Gh 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 307 KB

Management of the cardiac risk patient

✍ Johann Motsch 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Cancer Survivorship: Cardiotoxic Therapy

Cancer Survivorship: Cardiotoxic Therapy in the Adult Cancer Patient; Cardiac Outcomes With Recommendations for Patient Management

✍ Steingart, Richard M.; Yadav, Nandini; Manrique, Carlos; Carver, Joseph R.; Liu, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Proton Therapy in the Management of High

Proton Therapy in the Management of High-Risk Prostate Cancer

✍ Bryant, C.M.; Henderson, R.H.; Hoppe, B.S.; Mendenhall, W.M.; Nichols, R.; Su, Z 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 53 KB

The management of cardiac tamponade in p

The management of cardiac tamponade in patients with breast cancer

✍ Jacob D. Bitran; Richard Evans; Charles Brown 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 1 views

Six patients with disseminated breast cancer and cardiac tamponade were treated with a pleuropericardial window and in four patients with systemic chemotherapy. The median survival of these six patients was 17 months (range 1-50 months). These results indicate that aggressive therapy in patients wit